NFAT1信号通过调节脊柱微质中的IL-18表达来促进骨癌疼痛
Xuetai Chen1, Ying Zeng1, Zizhu Wang2
1Jiangsu Province Key Laboratory of Anesthesiology, Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Department of Anesthesiology, The Yancheng Clinical College of Xuzhou Medical University, The First people's Hospital of Yancheng, Yancheng, China.
脊柱微质中激活T细胞1 (NFAT1) 信号的核因子通过增加18 (IL-18) 介质素来驱动骨癌疼痛. 抑制NFAT1可以缓解疼痛行为,这表明NFAT1是治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 骨癌疼痛涉及复杂的机制,包括神经炎症.
- 脊柱微质在疼痛敏感化中起着至关重要的作用.
研究的目的:
- 调查激活T细胞1 (NFAT1) 核因子在脊髓微质中信号传递在骨癌疼痛中的作用.
- 为了确定NFAT1是否调节骨癌的骨癌疼痛的背景下介质素-18 (IL-18) 的表达.
主要方法:
- 我们使用了一种小鼠模型来研究由易斯肺癌引起的骨癌疼痛.
- 评估了知觉性行为 (机械律,热过敏,自发疼痛).
- 使用分子和成像技术分析了NFAT1和IL-18表达,p38 MAPK酸化和神经元/微质激活.
主要成果:
- 在瘤接种后,脊柱微质中NFAT1的表达显著上调.
- 药理上抑制NFAT1可以逆转和预防骨癌的疼痛行为.
- NFAT1抑制降低了p38 MAPK酸化和IL-18的产生,抑制了微质激活,并减弱了N-甲基-D-酸盐受体信号传递.
结论:
- 脊柱微质NFAT1-p38信号传递通过IL-18介导的中央敏感化促进骨癌疼痛.
- NFAT1代表了一种有前途的治疗点,用于治疗骨癌疼痛.
更多相关视频
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
09:52A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
相关概念视频
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The JAK-STAT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Canonical Wnt Signaling Pathway
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
![Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58491.jpg&w=3840&q=50)